A young mother has revealed the symptoms that led to her stage 3 colorectal diagnosis. About 150,000 Americans are diagnosed ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

About 150,000 Americans are diagnosed annually with colorectal cancer, which occurs when cells in the colon or rectum grow ...

Safety and tolerability of different total neoadjuvant therapy strategies in patients with locally advanced rectal cancer. First-in-human, phase 1a, dose escalation study of BGB-B167, a CEA x 4-1BB ...

2020年1月， 上海市同仁医院联合上海市浦东医院 在Oncology Reports（IF3.8001/3区）期刊上发表了一篇论文。在 发表5年后 ，因 与自己2019年发表的论文图片重复 在pubpeer上被读者质疑。

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it relates to recurrence in patients. As someone who has overcome colorectal cancer ...

In response to this concerning trend, the US Preventive Services Task Force updated its colorectal cancer screening ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Explore how cfDNA levels change around colorectal cancer surgery and their potential as non-invasive biomarkers for ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Old drugs from Bristol Myers Squibb and Pfizer have delivered what the companies and researchers believe could establish them ...

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel condensate-modulating mechanism of ...